Who owns TRANSCODE THERAPEUTICS INC COM NEW?
- Ticker: RNAZ
- CUSIP Number: 89357l303
Tip: Access positions for across all investors
Analyze quarterly positions in Transcode Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Transcode Therapeutics stock
Who bought or sold TRANSCODE THERAPEUTICS INC COM NEW this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Geode Capital Management | 122k | $70k | 217% | Sep 2024 |
|
Sheets Smith Wealth Management | 50k | $29k | 149% | Sep 2024 |
|
Jane Street | 40k | $23k | 100% | Sep 2024 |
|
Private Capital Management | 18k | $18k | 100% | Jun 2024 |
|
Captrust Financial Advisors | 16k | $9.3k | 44% | Sep 2024 |
|
Two Sigma Securities | 13k | $13k | -42% | Jun 2024 |
|
Morgan Stanley | 10k | $10k | 100% | Jun 2024 |
|
Tower Research Capital | 7.9k | $7.9k | 60% | Jun 2024 |
|
Bank of America Corporation | 141.00 | $81.004500 | 156% | Sep 2024 |
|
Who sold out of Transcode Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Citadel Advisors | Jun 2024 | 26k | $26k |
Susquehanna International | Jun 2024 | 24k | $24k |
Virtu Financial | Jun 2024 | 18k | $18k |
Financial Network Wealth Advisors | Jun 2024 | 1.0k | $1.0k |